Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Viruses · 2023
DOI: 10.3390/v15071436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Lisa Oestereich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany. Hauptthemen laut MEDLINE: Lassa Fever. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Leibniz Association.
Abstract (Originalsprache)
Background
Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease.
Methods
We used chimeric Ifnar−/− C57BL/6 (Ifnar−/− Bl6) mice, a lethal LASV mouse model, to evaluate the protective efficacy of polyclonal antibodies purified from sera of rabbits hyperimmunized with virus-like particles displaying native-like LASV glycoprotein GP spikes.
Results
Polyclonal anti-LASV GP antibodies provided 100% protection against lethal LASV infection in a pre- and post-exposure treatment setting and prevented LASV disease. Treatment also significantly lowered viremia level and virus load in organs. When treatment was initiated at the onset of symptoms, the hyperimmune antibodies provided partial protection and increased the survival rate by 80%.
Conclusions
Our findings support the consideration of animal-derived hyperimmune antibodies targeting GP as an effective treatment option for highly pathogenic LASV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
- German Center for Infectious Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, 20359 Hamburg, Germany.
- Institute of Virology, Philipps University Marburg, 35043 Marburg, Germany.
ORCID-Profile: Lisa Oestereich, Thomas Strecker
Förderung
- Deutsche Forschungsgemeinschaft
- Leibniz Association
Zitieren
APA
Oestereich, L., Müller-Kräuter, H., Pallasch, E., & Strecker, T. (2023). Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses. https://doi.org/10.3390/v15071436
Vancouver
Oestereich L, Müller-Kräuter H, Pallasch E, Strecker T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses. 2023. doi:10.3390/v15071436
BibTeX
@article{Oestereich2023,
author = {Oestereich, Lisa and Müller-Kräuter, Helena and Pallasch, Elisa and Strecker, Thomas},
title = {Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15071436}
}
EUVIMED